Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | RGS12 | O14924 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10914312 | 0.81 | TSHR (0.44) | TSHRRGS12BACE1TDP1LMNA | |
| SCHEMBL20435093 | 0.81 | TSHR (0.44) | TSHRRGS12BACE1TDP1LMNA | |
| SCHEMBL3282408 | 0.81 | TSHR (0.44) | TSHRRGS12BACE1TDP1LMNA | |
| SCHEMBL941641 | 0.78 | TSHR (0.41) | TSHRLMNAALDH1A1MAPT | |
| SCHEMBL7760124 | 0.76 | TSHR (0.40) | TSHRRGS12LMNA | |
| SCHEMBL6413977 | 0.72 | TSHR (0.40) | TSHRLMNAALDH1A1MAPT | |
| SCHEMBL112153 | 0.72 | TSHR (0.40) | TSHRRGS12LMNAALDH1A1MAPT | |
| SCHEMBL17676993 | 0.70 | CREBBP (0.58) | TSHRLMNAALDH1A1MAPT | |
| SCHEMBL18799320 | 0.70 | TSHR (0.48) | TSHRRGS12BACE1TDP1ALDH1A1 | |
| SCHEMBL9963916 | 0.69 | TSHR (0.34) | TSHRTDP1LMNAALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0759475-B1 | Method for the production of (R)-ter-leucine | DEGUSSA (DE) | 1999-08-25 | — | — | EP | claimed |
| JP-9103297-A | — | — | None | — | — | JP | disclosed |
| JP-7222593-A | — | — | None | — | — | JP | disclosed |
| US-20230348501-A1 | HETEROARYL INHIBITORS OF PDE4 | Tetra Discovery Partners, LLC | 2023-11-02 | — | — | US | disclosed |
| US-11767334-B2 | Heteroaryl inhibitors of PDE4 | Tetra Discovery Partners, LLC (US) | 2023-09-26 | — | — | US | disclosed |
| US-20230257367-A1 | NOVEL THYROID HORMONE BETA RECEPTOR AGONIST | CHENGDU KANGHONG PHARMACEUTICAL CO., LTD. (CN) | 2023-08-17 | — | — | US | disclosed |
| US-20230024240-A1 | HETEROARYL INHIBITORS OF PDE4 | Tetra Discovery Partners, LLC | 2023-01-26 | — | — | US | disclosed |
| CN-113861056-A | Synthetic method of hydrophilic micromolecule amino acid | 上海弘渼生物科技有限公司 | 2021-12-31 | — | — | CN | disclosed |
| US-20200354384-A1 | HETEROARYL INHIBITORS OF PDE4 | Tetra Discovery Partners, LLC | 2020-11-12 | — | — | US | disclosed |
| CN-111676256-A | Biological preparation method of L-tert-leucine | 南通大学 | 2020-09-18 | — | — | CN | disclosed |
| EP-0745678-A2 | Novel microorganism, its use and process for the preparation of L-alpha-aminoacids | Degussa Aktiengesellschaft (DE) | 1996-12-04 | — | — | EP | disclosed |
| US-5516660-A | FROM CORRESPONDING HYDANTOINS OR CARBAMOYL AMINO ACIDS;ENZYMATIC CONVERSION IN PRESENCE OF ARTHOBACTER | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1996-05-14 | — | — | US | disclosed |
| JP-H07222593-A | PRODUCTION OF N-CARBAMYL-L-TERT-LEUCINE | AJINOMOTO CO INC | 1995-08-22 | — | — | JP | disclosed |
| EP-0625571-A2 | Microorganisms, their use and method of production of L-alpha-amino acids | Degussa Aktiengesellschaft (DE) | 1994-11-23 | — | — | EP | disclosed |
| EP-0160618-B1 | HYDANTOIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | NIPPON ZOKI PHARMACEUTICAL CO. LTD. (JP) | 1991-08-14 | — | — | EP | disclosed |
| US-4332953-A | FOR PREPARING URETHANE FOAMS AND ELASTOMERS | BASF WYANDOTTE CORPORATION (US) | 1982-06-01 | — | — | US | disclosed |
| US-4331809-A | INTERMEDIATES FOR PREPARING POLYURETHANE FOAMS AND ELASTOMERS | BASF WYANDOTTE CORPORATION (US) | 1982-05-25 | — | — | US | disclosed |
| US-4331810-A | Carbamylbiuret-modified polyisocyanates | BASF WYANDOTTE CORPORATION (US) | 1982-05-25 | — | — | US | disclosed |
| US-4330636-A | Carbamylbiuret-modified polyisocyanates | BASF WYANDOTTE CORPORATION (US) | 1982-05-18 | — | — | US | disclosed |
| US-4271087-A | WHICH CAN ALSO CONTAIN GUANIDINE LINKAGES AND THIOUREA LINKAGES | BASF WYANDOTTE CORPORATION (US) | 1981-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354384-A1 | HETEROARYL INHIBITORS OF PDE4 | PDE4A, PDE4B, PDE4C | TSHR 3245/4885RGS12 750/4885BACE1 1626/4885 |
| US-20230024240-A1 | HETEROARYL INHIBITORS OF PDE4 | PDE4A, PDE4B, PDE4C | TSHR 3245/4885RGS12 750/4885BACE1 1626/4885 |
| US-20230348501-A1 | HETEROARYL INHIBITORS OF PDE4 | PDE4A, PDE4B, PDE4C | TSHR 3245/4885RGS12 750/4885BACE1 1626/4885 |
| US-11767334-B2 | Heteroaryl inhibitors of PDE4 | PDE4A, PDE4B, PDE4C | TSHR 3245/4885RGS12 750/4885BACE1 1626/4885 |
| US-20230257367-A1 | NOVEL THYROID HORMONE BETA RECEPTOR AGONIST | THRB, THRA, TSHR | TSHR 3/4885RGS12 1278/4885BACE1 1448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.